首页> 美国卫生研究院文献>other >Evaluating Disease Prediction Models using a Cohort whose Covariate Distribution Differs from that of the Target Population
【2h】

Evaluating Disease Prediction Models using a Cohort whose Covariate Distribution Differs from that of the Target Population

机译:使用协变量分布与目标人群的协变量分布不同的队列评估疾病预测模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Personal predictive models for disease development play important roles in chronic disease prevention. The performance of these models is evaluated by applying them to the baseline covariates of participants in external cohort studies, with model predictions compared to subjects’ subsequent disease incidence. However the covariate distribution among participants in a validation cohort may differ from that of the population for which the model will be used. Since estimates of predictive model performance depend on the distribution of covariates among the subjects to which it is applied, such differences can cause misleading estimates of model performance in the target population. We propose a method for addressing this problem by weighting the cohort subjects to make their covariate distribution better match that of the target population. Simulations show that the method provides accurate estimates of model performance in the target population, while un-weighted estimates may not. We illustrate the method by applying it to evaluate an ovarian cancer prediction model targeted to US women, using cohort data from participants in the California Teachers Study. The methods can be implemented using open-source code for public use as the R-package RMAP (Risk Model Assessment Package) available at .
机译:疾病发展的个人预测模型在慢性疾病预防中发挥重要作用。通过将这些模型应用于外部队列研究参与者的基线协变量来评估这些模型的性能,并将模型预测与受试者随后的疾病发生率进行比较。但是,验证队列中参与者之间的协变量分布可能与将使用该模型的人群的协变量分布不同。由于预测模型性能的评估取决于协变量在应用该模型的受试者之间的分布,因此这种差异会导致目标人群中模型性能的误导性估计。我们提出了一种通过加权同类受试者以使其协变量分布更好地匹配目标人群的方法来解决此问题的方法。仿真表明,该方法提供了目标人群中模型性能的准确估计,而未加权的估计则可能没有。我们通过使用来自加州教师研究参与者的队列数据,通过将其应用于评估针对美国女性的卵巢癌预测模型来说明该方法。可以使用公开代码作为R包RMAP(风险模型评估包)(可从处获得)来实现这些方法,以供公众使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号